Approval · Notice of Compliance 16606 · 2015
PRECEDEX: Notice of Compliance 16606
Issued February 16, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16606
- Date
- February 16, 2015
- Company
- Hospira Healthcare CorporationKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength
- Therapeutic class
- Alpha2-adrenergic agonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PRECEDEX | 02437147 | Marketed |
Medicinal ingredients
- DEXMEDETOMIDINE HYDROCHLORIDE 4 MCG per ML